Cargando…

Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients caused by heterozygous mutations in the HCN4 gene

Dilated cardiomyopathy (DCM) is a progressive heart muscle disease that can culminate with heart failure and death. Mutations in several genes can cause DCM, including hyperpolarization-activated cyclic nucleotide-gated channel (HCN4), which has a critical function in the autonomic control of the he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yildirim, Zehra, Kojic, Ana, Yan, Christopher D., Wu, Matthew A., Vagelos, Randall, Wu, Joseph C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881502/ https://www.ncbi.nlm.nih.gov/pubmed/36332467 http://dx.doi.org/10.1016/j.scr.2022.102951

Ejemplares similares

Generation of human induced pluripotent stem cell lines carrying heterozygous PLN mutation from dilated cardiomyopathy patients
por: Caudal, Arianne, et al.
Publicado: (2022)

Generation of three iPSC lines from dilated cardiomyopathy patients carrying a pathogenic LMNA variant
por: Lee, Chelsea, et al.
Publicado: (2022)

Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying TTN mutations
por: Zhang, Tina Tianbo, et al.
Publicado: (2022)

Heterozygous desmin gene (DES) mutation contributes to familial dilated cardiomyopathy
por: Huang, Ying-shuo, et al.
Publicado: (2021)

Generation of an induced pluripotent stem cell line from an individual with a heterozygous RECQL4 mutation
por: Jewell, Brittany E., et al.
Publicado: (2018)

Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathy
por: Schick, Revital, et al.
Publicado: (2018)

Correction: Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathy
Publicado: (2018)

Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying MYH7 mutations
por: Cao, Xu, et al.
Publicado: (2021)

Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying TNNI3 mutations
por: Zhao, Shane Rui, et al.
Publicado: (2021)

A novel de novo CASZ1 heterozygous frameshift variant causes dilated cardiomyopathy and left ventricular noncompaction cardiomyopathy
por: Guo, Jun, et al.
Publicado: (2019)

A novel heterozygous missense MYH7 mutation potentially causes an autosomal dominant form of myosin storage myopathy with dilated cardiomyopathy
por: Naderi, Niloofar, et al.
Publicado: (2023)

FLNC Gene Splice Mutations Cause Dilated Cardiomyopathy
por: Begay, Rene L., et al.
Publicado: (2016)

A Heterozygous ZMPSTE24 Mutation Associated with Severe Metabolic Syndrome, Ectopic Fat Accumulation, and Dilated Cardiomyopathy
por: Galant, Damien, et al.
Publicado: (2016)

Childhood onset nexilin dilated cardiomyopathy: A heterozygous and a homozygous case
por: Bruyndonckx, Luc, et al.
Publicado: (2021)

Generation of two induced pluripotent stem cell lines with heterozygous and homozygous amyotrophic lateral sclerosis-causing mutation P525L (c.1574C > T) in FUS gene
por: Akter, Masuma, et al.
Publicado: (2023)

Oxidative Stress in Dilated Cardiomyopathy Caused by MYBPC3 Mutation
por: Lynch, Thomas L., et al.
Publicado: (2015)

The Mutations Associated with Dilated Cardiomyopathy
por: Parvari, Ruti, et al.
Publicado: (2012)

Generation of two induced pluripotent stem cell lines with heterozygous and homozygous amyotrophic lateral sclerosis-causing mutation R521G (c.1561C > G) in FUS gene
por: Akter, Masuma, et al.
Publicado: (2023)

Generation of three induced pluripotent stem cell lines, SCVIi003-A, SCVIi004-A, SCVIi005-A, from patients with ARVD/C caused by heterozygous mutations in the PKP2 gene
por: Jahng, James W.S., et al.
Publicado: (2021)

Modeling of LMNA-Related Dilated Cardiomyopathy Using Human Induced Pluripotent Stem Cells
por: Shah, Disheet, et al.
Publicado: (2019)

Circular RNA Expression for Dilated Cardiomyopathy in Hearts and Pluripotent Stem Cell–Derived Cardiomyocytes
por: Zhang, Yiyu, et al.
Publicado: (2021)

Fatal neonatal hypertrophic cardiomyopathy caused by compound heterozygous truncating MYBPC3 mutation
por: Alsters, S., et al.
Publicado: (2019)

Genetic mutation of familial dilated cardiomyopathy based on next-generation semiconductor sequencing
por: Lin, Xin-Fu, et al.
Publicado: (2018)

Familial Dilated Cardiomyopathy Associated With a Novel Combination of Compound Heterozygous TNNC1 Variants
por: Landim-Vieira, Maicon, et al.
Publicado: (2020)

Familial dilated cardiomyopathy associated with a novel heterozygous RYR2 early truncating variant
por: Costa, Sarah, et al.
Publicado: (2021)

Generation of two heterozygous MYBPC3 mutation-carrying human iPSC lines, SCVIi001-A and SCVIi002-A, for modeling hypertrophic cardiomyopathy
por: Liu, Lichao, et al.
Publicado: (2021)

Reversible dilated cardiomyopathy caused by hypothyroidism
por: Khochtali, I, et al.
Publicado: (2011)

Induced Pluripotent Stem Cell (iPSC) Lines from a Family with Resistant Epileptic Encephalopathy Caused by Compound Heterozygous Mutations in SZT2 Gene
por: Cattelani, Cecilia, et al.
Publicado: (2022)

Inherited dilated cardiomyopathy in a large Moroccan family caused by LMNA mutation
por: Adadi, Najlae, et al.
Publicado: (2018)

A Novel Recessive Mutation in SPEG Causes Early Onset Dilated Cardiomyopathy
por: Levitas, Aviva, et al.
Publicado: (2020)

Salts of HCN‐Cyanide Aggregates: [CN(HCN)(2)](−) and [CN(HCN)(3)](−)
por: Bläsing, Kevin, et al.
Publicado: (2020)

Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy
por: Lin, Bo, et al.
Publicado: (2015)

Enhancement of pacing function by HCN4 overexpression in human pluripotent stem cell-derived cardiomyocytes
por: Saito, Yukihiro, et al.
Publicado: (2022)

Dilated-Left Ventricular Non-Compaction Cardiomyopathy in a Pediatric Case with SPEG Compound Heterozygous Variants
por: Jaouadi, Hager, et al.
Publicado: (2022)

Compound Heterozygous FKTN Variants in a Patient with Dilated Cardiomyopathy Led to an Aberrant α-Dystroglycan Pattern
por: Gaertner, Anna, et al.
Publicado: (2022)

OBSCN Mutations Associated with Dilated Cardiomyopathy and Haploinsufficiency
por: Marston, Steven, et al.
Publicado: (2015)

Generation of two induced pluripotent stem cell lines (CHOCi002-A and CHOCi003-A) from Pompe disease patients with compound heterozygous mutations in the GAA gene
por: Christensen, Chloe, et al.
Publicado: (2023)

Reversible dilated cardiomyopathy caused by idiopathic hypoparathyroidism
por: Jung, Youn Joo, et al.
Publicado: (2013)

A rare cause of dilated cardiomyopathy: hypocalcemia
por: Mutlu, Ummu, et al.
Publicado: (2022)

Investigating LMNA-Related Dilated Cardiomyopathy Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Shemer, Yuval, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6duff3oigel4o5ttso2kgnn0kk